Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - hematology - the cell-dyn ruby system is a multi-parameter automated hematology analyzer designed for ivd use in clin. lab. reticulocyte rgt. for use in the determination of reticulocyte % for cell-dyn ruby® & cell-dyn 3200/3500/3700 systems. cell-dyn hemcal plus calibrator is a wb cal. used to calibrate cell-dyn hematology systems. cell-dyn 26 plus tri-level control is an assayed hematology control for evaluating the accuracy and precision of hematology instruments that provide a wb cell differential. cell-dyn 29 plus control (with retic) is a wb hematology quality control mtrl. used to monitor results obtained on cell-dyn hematology systems. a reticulocyte control used to monitor reticulocyte values on the cell-dyn 3200/3500/3700/4000 & cell-dyn ruby® systems.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - hematology - the cell-dyn sapphire is a multi-parameter automated hematology analyzer designed for in vitro diagnostic use in counting and characterizing blood cells. cell-dyn 29 plus control (with retic) is a whole blood hematology quality control material used to monitor results obtained on cell-dyn hematology systems. cell-dyn hemcal plus calibrator is a whole blood calibrator used to calibrate cell-dyn hematology systems. calibration values are provided for wbc, rbc, hgb, mcv, plt, and mpv parameters. cell-dyn immunoplt (cd61) reagent is a one-color direct immunofluorescence reagent for enumerating platelets in human whole blood. immuno t-cell (cd3/4/8) reagents for use on cell-dyn sapphire™ and cell-dyn 4000 hematology analyzers.

Canada - English - Health Canada

astrazeneca canada inc - acalabrutinib (acalabrutinib maleate) - tablet - 100mg - acalabrutinib (acalabrutinib maleate) 100mg

Canada - English - Health Canada

astrazeneca canada inc - acalabrutinib - capsule - 100mg - acalabrutinib 100mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - acalabrutinib (unii: i42748elqw) (acalabrutinib - unii:i42748elqw) - calquence is indicated for the treatment of adult patients with mantle cell lymphoma (mcl) who have received at least one prior therapy. this indication is approved under accelerated approval based on overall response rate [see clinical studies (14.1)] . continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. calquence is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll). none. risk summary based on findings in animals, calquence may cause fetal harm and dystocia when administered to a pregnant woman. there are no available data in pregnant women to inform the drug-associated risk. in animal reproduction studies, administration of acalabrutinib to animals during organogenesis resulted in dystocia in rats and reduced fetal growth in rabbits at maternal exposures (auc) 2 times exposures in patients at the recommended dose of 100 mg approximately every 12 hours (s

Israel - English - Ministry of Health

rafa laboratories ltd - minocycline as hydrochloride - capsules - minocycline as hydrochloride 50 mg - minocycline - minocycline - treatment of infections caused by minocycline-sensitive micro-organisms including acne, gonorrhea and prophylaxis of asymptomatic meningococcal carrier.

Israel - English - Ministry of Health

rafa laboratories ltd - minocycline as hydrochloride - capsules - minocycline as hydrochloride 100 mg - minocycline - minocycline - treatment of infections caused by minocycline-sensitive micro-organisms including acne, gonorrhea and prophylaxis of asymptomatic meningococcal carrie.

Israel - English - Ministry of Health

rafa laboratories ltd - diltiazem hydrochloride - capsules controlled release - diltiazem hydrochloride 120 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

Israel - English - Ministry of Health

rafa laboratories ltd - diltiazem hydrochloride - capsules controlled release - diltiazem hydrochloride 180 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

Israel - English - Ministry of Health

rafa laboratories ltd - diltiazem hydrochloride - capsules controlled release - diltiazem hydrochloride 240 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.